Neogenomics Inc
Research Neogenomics Inc (NEO) on Bullrun: market cap USD 1.86B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNEO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 1.86B
- Financial periodFY2025
- RevenueUSD 727.33M
- Revenue growth10.1%
- Net income-USD 108.00M
- Free cash flow-USD 21.78M
- Gross margin43.2%
Valuation Snapshot
latest market cap is USD 1.86B.
About Neogenomics Inc
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases;
Frequently asked questions
What is Neogenomics Inc's market cap?
Neogenomics Inc's market capitalization is USD 1.86B.
What does Neogenomics Inc do?
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.